Remove 2003 Remove 2022 Remove Blog Remove Public Health
article thumbnail

April-July 2022 State Regulatory Developments

New Jersey Healthcare Blog

Below are the most recent health care related regulatory developments as published in the New Jersey Register in April-July 2022: April 2022. On April 4, 2022, at 54 N.J.R. On April 4, 2022, at 54 N.J.R. 290 (2022). On April 4, 2022, at 54 N.J.R. 292 (2022). On April 4, 2022, at 54 N.J.R.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

In August 2022, ANVISA published Resolution RDC 741/2022 , which sets the framework to consider other medical device market regulators’ authorizations. mg Strengths) Due to Possible Device Failure, 05 May 2023 Bausch Health, Canada Inc. The affected lots of Emerade were distributed in Canada between April 2022 and May 2023.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Access to Reproductive Technology May Be Impeded by Workplace Law and Policy in South Africa

Bill of Health

This constitutional right is further supported by the National Health Act and its Regulations relating to the artificial fertilization of persons, and the regulations relating to tissue, cells, organs, blood, blood products and gametes.

article thumbnail

Terrible Decision Contravenes the Vaccine Act’s Purpose and Would Gut Its Protections

Drug & Device Law

Some of us on the Blog are veterans of the original vaccine wars – those that preceded the enactment of the Vaccine Act, 42 U.S.C. GlaxoSmithKline PLC , 2022 WL 17338047 (E.D.N.Y. 29, 2022), which (if allowed to stand) imperils everything that Congress and the Supreme Court accomplished through the Vaccine Act. Merck & Co.

FDA 115